Emblem Corp. Shareholders Approve Proposed Arrangement with Aleafia Health, Announces Results of Special Meeting
The Arrangement creates:
The leading Canadian medical cannabis clinic and education centre network with 60,000 patients seen to date
A high-value, highly differentiated medical product portfolio of oils, capsules and sprays
Scaled production capacity and leading supply with three dedicated cultivation and product innovation facilities and industry’s largest LP to LP cannabis supply agreement
A national and global distribution platform with provincial supply agreements, retail partnerships and global partnerships operating in the European Union and Australia
Improved capital markets profile, with broader shareholder base and improved liquidity
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.